A 12-week trial of patients receiving semaglutide demonstrated an 11.85% reduction in body weight from baseline, greater than that seen with diet and exercise alone
Risk of Pancreatitis: There is a concern with GLP-1 receptor agonists, including Semaglutide, regarding an increased risk of pancreatitis
For custom guidance and to see if Semaglutide GLP-1 suits you, reach out to us or schedule an online appointment at Reliable MD
One aspect that often raises concerns regarding medications is their potential impact on body weight
Alyssa Dominguez, an endocrinologist with Keck Medicine of USC in Los Angeles, says some of her patients also ask about pausing doses during the holidays
Why It's Unique Fridays provides access to compounded medications with licensed clinician oversight, making advanced therapies more affordable and approachable through a telehealth platform